Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Actinium Pharmaceuticals (ATNM) Return on Assets (2021 - 2025)

Actinium Pharmaceuticals (ATNM) has disclosed Return on Assets for 6 consecutive years, with 0.48% as the latest value for Q3 2024.

  • On a quarterly basis, Return on Assets rose 8.0% to 0.48% in Q3 2024 year-over-year; TTM through Sep 2024 was 0.48%, a 8.0% increase, with the full-year FY2023 number at 0.5%, down 15.0% from a year prior.
  • Return on Assets was 0.48% for Q3 2024 at Actinium Pharmaceuticals, up from 0.48% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.18% in Q2 2021 to a low of 0.58% in Q4 2023.
  • A 4-year average of 0.44% and a median of 0.48% in 2024 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: rose 21bps in 2022, then decreased -29bps in 2023.
  • Actinium Pharmaceuticals' Return on Assets stood at 0.51% in 2021, then soared by 42bps to 0.3% in 2022, then crashed by -98bps to 0.58% in 2023, then rose by 19bps to 0.48% in 2024.
  • Per Business Quant, the three most recent readings for ATNM's Return on Assets are 0.48% (Q3 2024), 0.48% (Q2 2024), and 0.55% (Q1 2024).